Typically characterised by a lack of oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2), TNBC is characterised by a higher degree of aggressiveness, tumour burden and poorer prognosis compared with other subtypes [2]. This evidence concerns the gene ERBB2 and neoplasm.